Elaine Stead's Investment Thesis
In this session, we sit down with investor Elaine Stead.
Elaine Stead is a Principal at Main Sequence, with a focus on the “Humanity Scale Healthcare” challenge. With a background spanning science, entrepreneurship, and venture capital, she holds a Ph.D. in Biochemistry (Stem Cell Biology) and a B.Sc.in Biochemistry and Microbiology, and has also been a founder of venture businesses, including Blue Sky VC, Human VC and Tribe Global Ventures. In all avenues, Elaine prioritises human-centricity, emphasising authentic connections, vulnerability, and compassion, advocating for values-driven innovation and a desire to make better that which can be.
Building an investment thesis from the ground up — one conversation at a time.
Bring your thesis to the table.
Have an investment perspective worth exploring? Book a conversation with the Investment Thesis team.
Other Day One shows worth a listen
Episodes from across the network exploring similar themes — part of the same Day One conversation.
▶First Cheque with Cheryl Mack & Maxine Minter
From Scalpel to Syndicate: Paul Kelly's Guide to Navigating Biotech Investing
2 September 2024
▶What The Health with Emily Casey
Longevity BS, Breakthroughs and What Comes Next
15 October 2026
▶In The Blink Of AI with Georgie Healy
We're Afraid of the Wrong Thing in AI — with Paloma Newton
21 August 2026
Turn podcasting into pipeline
Produced by W2D1 Media. We're the team behind the Day One Network, and we helped build Blackbird Ventures' Wild Hearts. We help founders, funds and operators build trust, authority and deal flow with a show tailored to their market.
